Contact
/
Home
/
About
Team
Portfolio
Exit History
News
About
Team
Portfolio
Exit History
News
Advent Life Sciences
Advent Life Sciences
Page 3 of 16
<< Start
< Prev
1
2
3
4
5
6
7
8
9
10
Next >
End >>
30.09.2015
Advent Life Sciences announces the Appointment of Roy Lobb as Venture Partner
Press Release
23.09.2015
Advent Life Sciences announces the appointment of Mary Kerr as Operating Partner
Press Release
22.09.2015
Artax Biopharma Funded to Clinically Develop Breakthrough Oral Therapies for Autoimmune Diseases
Press Release
21.09.2015
Positive Topline Results Announced from Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure’s Novel AAV5-Based Gene Therapy
Press Release
13.07.2015
EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CARDIAQ
Press Release
10.07.2015
Success of Cellnovo’s IPO with €31.6 million raised on Euronext in Paris
Press Release
24.04.2015
BIOCARTIS RAISES EUR 100 MILLION IN SUCCESSFUL INITIAL PUBLIC OFFERING
Press Release
06.03.2015
Aura Biosciences Closes $21M Series B Financing
Press Release
04.03.2015
Macrolide Pharmaceuticals, Inc. Raises $22 Million in Series A Financing
Press Release
21.01.2015
Versartis Announces Pricing of Follow - On Offering
Press Release
©2019 Advent Life Sciences